| EMA number | EMEA/H/C/000311 |
| ATC code | R06AX27 |
| Authorisation | 15 January 2001 |
| Withdrawn | 10 March 2004 |
| Revision | - |
Opulis is indicated for the relief of symptoms associated with:- allergic rhinitis (see section 5.1)- urticaria (see section 5.1)
CLARINEX — ORGANON, approved 2019-03-15 (NDA021165).
6,552 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.